Acute respiratory distress syndrome resulting from inhalation of powdered copper

Clinical Toxicology

Volumn 45, Issue 6, 2007, Pages 714-716

  Donoso, Alejandro ^a   Cruces, Pablo ^a   Camacho, Jorge ^a   Ríos, Juan Carlos ^b,c   Paris, Enrique ^b   Mieres, Juan Jose ^b  

^a UNIVERSIDAD DEL DESARROLLO   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c CITUC   (Chile)

Author keywords

Acute respiratory distress syndrome; ARDS; Children poisoning; Copper poisoning

Indexed keywords

CEFOTAXIME; COPPER; DEXAMETHASONE; DIURETIC AGENT; FUROSEMIDE; MIDAZOLAM; PENICILLIN G;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; BLOOD LEVEL; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; EMERGENCY WARD; EXTUBATION; FEMALE; FIBEROPTIC BRONCHOSCOPY; HEMOLYTIC ANEMIA; HIGH FREQUENCY OSCILLATION; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; INTENSIVE CARE UNIT; KIDNEY CONCENTRATING CAPACITY; KIDNEY FAILURE; LABORATORY TEST; LIVER FAILURE; LUNG LAVAGE; MACROPHAGE; PRESCHOOL CHILD; RESPIRATORY FAILURE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VITAL SIGN;

CHILD, PRESCHOOL; COPPER; FEMALE; HUMANS; INHALATION EXPOSURE; POWDERS; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME;

EID: 34548619363     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701438912     Document Type: Article

References (14)

1. Editorial Staff. Copper (Management/Treatment Protocol). In: Klasco RK, ed. POISINDEX® System. Thomson Micromedex, Greenwood Village, Colorado (6/2006).
2. Bingham E, Cohrssen B, Powell CH. Patty's Toxicology, vol. 2, 5th ed. New York: John Wiley & Sons, 2001.
3. th ed. New York: Appleton & Lange, 2002:1262-1271.
4. Barranco VP. Eczematous dermatitis caused by internal exposure to copper. Arch Dermatol 1972; 106:386-387.
5. Kurisaki E, Kuroda Y, Sato M. Copper-binding protein in acute copper poisoning. Forens Sci Internat 1988; 38:3-11.
6. Dowdy RP. Copper metabolism. Am J Clin Nutr 1969; 22:887-892.
7. Bentur Y, Koren G, McGuigan M. An unusual skin exposure to copper: Clinical and pharmacokinetic evalution. Clin Toxicol 1988; 26:371-380.
8. Barceloux DG. Copper. Clin Toxicol 1999; 37:217-230.
9. Ruffing R. Copper: Normal metabolism, poisoning and a review of Palm Island mystery disease, unpublished, 1988.
10. Metz EN, Sagone AL. The effect of copper on the erythrocyte hexose monophosphate shunt pathway. J Lab Clin Med 1972; 80:405-413.
11. Owen CA Jr, Randall RV, Goldstein NP. Effect of dietary D-penicillamine on metabolism of copper in the rat. Am J Physiol 1975;228(1):88-91.
12. Bhusnurmath SR, Walia BNS, Singh S. Sequential histopathologic alterations in Indian childhood cirrhosis treated with d-Penicillamine. Human Pathol 1991; 22:653-658.
13. Rodeck B, Kardoff R, Melter M. Treatment of copper associated liver disease in childhood. Eur J Med Res 1999; 4(6):253-6.
14. Mitchell WM, Basinger MA, Jones MM. Antagonism of acute copper(II)-induced renal lesions by sodium 2,3-dimercaptopropanesulfonate. Johns Hopkins Med J 1982; 151(6):283-5.